 |
Molika Ashford is a GenomeWeb contributing editor and covers personalized medicine and molecular diagnostics. E-mail Molika Ashford. |
Case Study Suggests FISH Test May Miss Some Patients Who Could Benefit from Crizotinib
September 12, 2012
Case Study Suggests FISH Test May Miss Some Patients Who Could Benefit from Crizotinib
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Pfizer and Collaborators Developing Next-Gen Sequencing Test for Crizotinib Resistance Mutations
March 27, 2013 / Pharmacogenomics Reporter - GenomeWeb Feature: The Rise of Lung Cancer Genetic Testing
May 8, 2013 / Pharmacogenomics Reporter - Lab21 Offering Companion Testing to Personalize ALK Inhibitors for NSCLC Patients
February 22, 2012 / Pharmacogenomics Reporter - Pfizer, Collaborators Developing NanoString ALK Test as Lower-Cost Alternative to FISH, IHC
December 19, 2012 / Pharmacogenomics Reporter - UK Study Suggests VEGF Splice Isoform Ratio Could Predict Colorectal Cancer Patients' Avastin Response
November 2, 2012 / Pharmacogenomics Reporter